Key result
LGE CMR identifies focal myocardial enhancement in 100% of patients with specific cardiomyopathies.
Why the study?
Can late gadolinium enhancement CMR visualize regions of abnormal myocardium in specific cardiomyopathies?
Observational (n=9)
Can late gadolinium enhancement CMR visualize regions of abnormal myocardium in specific cardiomyopathies?
Late gadolinium enhancement CMR can identify focal myocardial abnormalities in specific cardiomyopathies, demonstrating patterns distinct from ischemic injury.
Answers are grounded in this paper and cite their sources.
May support CMR visualization of abnormalities in specific cardiomyopathies; leaves open diagnostic utility pending larger prospective studies.
Late gadolinium enhancement cardiovascular magnetic resonance (CMR) can visualize myocardial interstitial abnormalities. The aim of this study was to assess whether regions of abnormal myocardium can also be visualized by late enhancement gadolinium CMR in the specific cardiomyopathies. A retrospective review of all referrals for gadolinium CMR with specific cardiomyopathy over 20 months. Nine patients with different specific cardiomyopathies were identified. Late enhancement was demonstrated in all patients, with a mean signal intensity of 390 +/- 220% compared with normal regions. The distribution pattern of late enhancement was unlike the subendocardial late enhancement related to coronary territories found in myocardial infarction. The affected areas included papillary muscles (sarcoid), the mid-myocardium (Anderson-Fabry disease, glycogen storage disease, myocarditis, Becker muscular dystrophy) and the global sub-endocardium (systemic sclerosis, Loeffler's endocarditis, amyloid, Churg-Strauss). Focal myocardial late gadolinium enhancement is found in the specific cardiomyopathies, and the pattern is distinct from that seen in infarction. Further systematic studies are warranted to assess whether the pattern and extent of late enhancement may aid diagnosis and prognostic assessment.
No takes yet. Share an insight, caveat, or question.
Silva et al. (2007) conducted an observational in specific cardiomyopathies (n=9). Late gadolinium enhancement cardiovascular magnetic resonance was evaluated on Presence of late enhancement. Late gadolinium enhancement CMR demonstrated focal myocardial late enhancement in 100% of patients with specific cardiomyopathies, with a mean signal intensity of 390 +/- 220% versus normal regions.
Synapse has enriched 10 related papers. Consider them for comparative context: